OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 W... ( ARLINGTON Texas span class xn-chr.....)

OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase

Date:3/16/2010

ARLINGTON, Texas, March 16 /PRNewswire/ -- OrthoAccel Technologies, Inc. is among the over 100 companies and technology innovators from across the nation and around the world that will compete for top honors at the WBT2010, March 16-17 in Arlington-DFW, Texas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

OrthoAccel's AcceleDent System, an acceleration device to enhance orthodontics, will be rigorously prepped by WBTshowcase commercialization experts to present to participants including venture capitalists and Fortune 1000 licensees. Over 500 professionals attended last year's event.

"The conventional wisdom for venture capital is that a down economy can be a great time to invest," said Paul Huleatt, WBTshowcase CEO. "The pace of new innovations accelerates, the best deals rise quickly to the top and sophisticated investors receive great value for their money."

SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
5. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
8. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
11. Orchid Cellmark to Purchase ReliaGene Technologies, Inc.

Post Your Comments:

(Date:5/16/2013)... Vernon Hills, Ill. (PRWEB) May 16, 2013 ... including benchtop and portable models, from Cole-Parmer is ... professionals. The enhanced line includes: , The new ... that are true workhorses in the lab. They ... superior serum and plasma specimen separation. Their standard ...

(Date:5/16/2013)... May 16, 2013 The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...

(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ... The new ...

(Date:5/16/2013)... Dr. Stephen Y. Chou, Founder of Nanonex ... and Applications” at IEEE Nano 2013 in Beijing, China, ... by Chou, is becoming one of the most critical ... sub-10 nm resolution, large area, and low cost unmatchable ... and manufacturing in a broad range of industries, from ...

Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2 Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2 Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3 Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7 Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8 Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2

[0] Cole-Parmer Offers Enhanced Selection of Centrifuges [0] Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego [0] Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors [0] Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013

... In the news release, "Health Robotics Reports Record-Breaking Revenues,EBITDA, Net Profits, and Cash-Flow for its Fiscal Year 2009" ... the company that "EUR VAR" has been changed to "$ VAR" in,the third column header of both tables. Complete, corrected release follows: ... ... , ...

... , GREAT RIVER, N.Y. , March 15 ... enterprise-wide software and services for health and human services ... the next generation of the company,s industry leading electronic ... My Avatar software is being demonstrated at the National ...

... ... ... - Interaction of nimotuzumab with EGFRvIII, ... , , ...

/C O R R E C T I O N -- Health Robotics/Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations

(Date:5/17/2013)... An international team of scientists using a new X-ray ... a living frog embryo in greater detail than ever ... biological research and the search for new treatments for ... Institut fr Technologie in Germany, in collaboration with the ... Argonne National Laboratory, released the most precise depiction ever ...

(Date:5/16/2013)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for The Society for Developmental Biology (SDB) ... 16-20, 2013. These awards are meant to promote ... underrepresented groups into the mainstream of the basic ... young scientists at the SDB 2013 Annual Meeting. ...

(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...

Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2 Gene involved in neurodegeneration keeps clock running 2

[0] New X-ray method shows how frog embryos could help thwart disease [0] MARC Travel Awards announced for the SDB 2013 72nd Annual Meeting [0] Gene involved in neurodegeneration keeps clock running

... that allergic infants may be at increased risk of peanut ... are reported in the November 1 issue of the ... Scott H. Sicherer, MD, Professor of Pediatrics, Jaffe Food Allergy ... U.S. study sites evaluated 503 infants aged three to 15 ...

... MADISON -- They are the portals to the cell, ... living cells and their environments. But these gateways -- ... outside the cell to its vital inner workings remain, ... their structures and how they work. They are of intense ...

... have shown how a protein called perforin punches holes in, ... the mechanism of this assassin is published today in the ... of cleansing and death," says project leader Prof James Whisstock ... been hijacked by viruses or turned into cancer cells and ...

Cached Biology News:Pregnant women who eat peanuts may put infants at increased risk for peanut allergy 2 Chemists concoct new agents to easily study critical cell proteins 2 How do we kill rogue cells? 2

Pregnant women who eat peanuts may put infants at increased risk for peanut allergy Chemists concoct new agents to easily study critical cell proteins How do we kill rogue cells?

Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...

Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...

HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....

Human CXCL14/BRAK Affinity Purified Polyclonal Ab...

Biology Products:

Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems Goat Anti-Mouse NOV / CCN3 Polyclonal Antibody, Unconjugated from R&D Systems HiTrap NHS-activated HP from GE Healthcare, formerly Amersham Biosciences Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems